Search filters

List of works by Jonathan E Rosenberg

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

scientific article

A phase II trial of durvalumab and tremelimumab in metastatic, non-urothelial carcinoma of the urinary tract

scientific article published on 31 December 2020

Actionable mutations in muscle-invasive bladder cancer.

scientific article published on September 2013

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib

scientific article

Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter.

scientific article published on 10 May 2013

Advanced Urothelial Carcinoma: Overcoming Treatment Resistance through Novel Treatment Approaches ⬇️

scientific article published on February 6, 2013

Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype

scientific article published in 2022

Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base

scientific article

Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer.

scientific article published on 6 January 2012

Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma.

scientific article published on 2 October 2014

Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis.

scientific article

Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-2

scientific article published on 20 May 2020

Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group

scientific article published on 01 March 2013

DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma

scientific article published on 30 January 2017

DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors

scientific article published on 9 April 2015

Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer

scientific article published on 13 September 2018

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees

scientific article published on 19 November 2019

Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma

scientific article

Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer

scientific article published in 2023

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder

scientific article published on 21 May 2014

First-line treatment and prognostic factors of metastatic bladder cancer for platinum-eligible patients

scientific article published on 15 December 2014

Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma

scientific article published on 14 January 2016

Genomic Characterization of Upper Tract Urothelial Carcinoma

scientific article

Genomic characterization of response to chemoradiation in urothelial bladder cancer

scientific article

Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder

scientific article

HER2 as a target in invasive urothelial carcinoma

scientific article published on 26 February 2015

Identification of ALK gene alterations in urothelial carcinoma

scientific article

Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.

scientific article

Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design.

scientific article published on 9 June 2014

Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial Carcinoma

scientific article published on 17 August 2015

Incidence and Effect of Thromboembolic Events in Radical Cystectomy Patients Undergoing Preoperative Chemotherapy for Muscle-invasive Bladder Cancer

scientific article published on 10 August 2017

Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial Design

scientific article published on 7 November 2014

Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect

scientific article published on 11 July 2019

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

scientific article published in 2022

Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma?

scientific article published on 14 December 2015

Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials

scientific article published on 07 September 2018

Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma.

scientific article published on 7 August 2015

Molecular targets on the horizon for kidney and urothelial cancer

scientific article published on 27 August 2013

Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates

scientific article published on 12 May 2014

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets

scientific article published on 2 June 2017

Novel molecular targets for urothelial carcinoma

scientific article published on 30 January 2015

Optimal treatment for metastatic bladder cancer

scientific article

Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma.

scientific article published on 10 June 2014

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma

scientific article

Prognostic Value of TERT Alterations, Mutational and Copy Number Alterations Burden in Urothelial Carcinoma

scientific article published on 9 August 2017

Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.or

scientific article published on 12 March 2015

Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye

Six-month progression-free survival as the primary endpoint to evaluate the activity of new agents as second-line therapy for advanced urothelial carcinoma

scientific article published on 28 September 2013

Slowing late infantile Batten disease by direct brain parenchymal administration of a rh.10 adeno-associated virus expressing <i>CLN2</i>

scientific article published on 01 December 2020

Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors

scientific article published on 3 June 2015

Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma

scientific article

Specific PPAR gamma agonists may have different effects on cancer incidence

scientific article published in March 2013

Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer ⬇️

scientific article published on 27 April 2016

Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward.

scientific article

Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy

scientific article published on 16 June 2014

The evolving understanding of microRNA in bladder cancer ⬇️

scientific article published on August 2, 2013

The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma.

scientific article

The role of genomics in the management of advanced bladder cancer

scientific article

The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experience

scientific article published on 6 April 2015

Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study

scientific article published on 08 February 2020

Paulina is supported by:

About Paulina

Help